QSAM Biosciences Unternehmenswert
Was ist das Unternehmenswert von QSAM Biosciences?
Unternehmenswert von QSAM Biosciences, Inc. ist $10.28M
Was ist die Definition von Unternehmenswert?
Der Unternehmenswert ist ein Maß für den gesamten Marktwert eines Unternehmens. Es wird als Marktkapitalisierung mit Verschuldung, Minderheitsanteilen und Vorzugsaktien abzüglich der Zahlungsmittel und Zahlungsmitteläquivalente berechnet.
It is a sum of claims by all claimants including creditors (secured and unsecured) and shareholders (preferred and common). Enterprise value is one of the fundamental metrics used in business valuation, financial modeling, accounting, portfolio analysis, and risk analysis. Enterprise value is more comprehensive than market capitalization, which only reflects common equity and is considered more representative of a company’s value. Enterprise value reflects the opportunistic nature of business and may change substantially over time because of both external and internal conditions.
Enterprise value can be negative if the company holds abnormally high amounts of cash that is not reflected in the market value of the stock and total capitalization. Cash is subtracted in the calculation because it reduces the net cost to a potential purchaser. The effect applies whether the cash is used to issue dividends or to pay down debt. Value of minority interest is added because it reflects the claim on assets consolidated into the firm in question. Value of associate companies is subtracted because it reflects the claim on assets consolidated into other firms. EV should also include such special components as unfunded pension liabilities, employee stock options, environmental provisions, abandonment provisions, and so on, since they also reflect claims on the company.
Unternehmenswert von Unternehmen in Health Care Sektor auf OTC im Vergleich zu QSAM Biosciences
Was macht QSAM Biosciences?
QSAM Biosciences, Inc., a clinical stage biotechnology company, develops drugs for the treatment of bone cancer. The company is involved in the development of CycloSam (Samaium-153 DOTMP), a clinical-stage novel radiopharmaceutical for the treatment of bone cancer and related diseases. It has a license agreement with IGL Pharma, Inc. The company was formerly known as Q2Earth, Inc. and changed its name to QSAM Biosciences, Inc. in September 2020. QSAM Biosciences, Inc. was founded in 2004 and is based in Austin, Texas.
Unternehmen mit unternehmenswert ähnlich QSAM Biosciences
- NXT Solutions hat Unternehmenswert von $10.26M
- National Plastic Industries hat Unternehmenswert von $10.26M
- Lake Winn Resources Corp hat Unternehmenswert von $10.26M
- Boreal Metals hat Unternehmenswert von $10.26M
- Dragon King hat Unternehmenswert von $10.27M
- Therma Bright hat Unternehmenswert von $10.28M
- QSAM Biosciences hat Unternehmenswert von $10.28M
- Grid Metals hat Unternehmenswert von $10.28M
- Fox Marble PLC hat Unternehmenswert von $10.29M
- Coral India Finance and Housing hat Unternehmenswert von $10.30M
- Trejhara Solutions hat Unternehmenswert von $10.31M
- Sprout Tiny Homes hat Unternehmenswert von $10.31M
- Oculus VisionTech hat Unternehmenswert von $10.32M